Mirum Pharmaceuticals (MIRM)
(Delayed Data from NSDQ)
$24.55 USD
-0.92 (-3.61%)
Updated May 24, 2024 04:00 PM ET
After-Market: $24.57 +0.02 (0.08%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Mirum Pharmaceuticals, Inc. [MIRM]
Reports for Purchase
Showing records 81 - 99 ( 99 total )
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
AASLD Recap: 7 Hidden Gems That Caught Our Eyes in Boston
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Earnings Recap: Halftime Show of Our Most In-Depth, Differentiated Earnings Yet
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
3Q19 AASLD Presentations Could Secure ALGS Regulatory Filing
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Should You Attend AASLD in Boston? Use Our Day-By-Day Calendar to Figure It Out
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare -The Liver Meeting Abstracts Part 4: Late-Breaker Abstracts for AASLD Out
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from our Expert Call with Dr. Nancy Spinner
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
See ALGS Through the Eyes of a Geneticist: Dial in on Oct. 10th at 12PM ET
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - The Liver Meeting Abstracts Part 2: Our Coverage Universe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Earnings Recap: The More Analysis, The Merrier, Especially When Data-Driven
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mirum Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
We initiate coverage with a Buy rating and a $33 price target
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y